Skip to main content

Deep Vein Thrombosis - Prophylaxis News

Clot Risk High With Oral Contraceptives for Those at Genetic Risk

FRIDAY, Dec. 1, 2023 – Oral contraceptive (OC) use is associated with an increased risk for developing a venous thromboembolism (VTE), particularly among women with a high genetic predisposition,...

ASCO: Direct Oral Anticoagulant Therapy Feasible for Cancer Patients

TUESDAY, June 6, 2023 – Direct oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients,...

FDA Medwatch Alert: Eliquis (apixaban) 5 mg tablets: Recall One Lot- Bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets

ISSUE: Bristol-Myers Squibb Company is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the U.S. to wholesalers and retail...

FDA Expands Use of Xarelto to Treat, Reduce Recurrence of Blood Clots

November 2, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis (DVT), Deep Vein Thrombosis

Related drug support groups

Xarelto, Eliquis, Lovenox, Pradaxa, apixaban